Fig. 3: Summary of metastatic breast cancers with SMARC alterations.

(A) cases are shown in columns and genes with genetic alterations in rows. Clinicopathologic characteristics and Class designation are depicted in phenotype bars (B) comparison of somatic mutations and copy number alterations between Class 1 and 2 (C) distribution of SMARCA4 and SMARCB1 alterations.